US to review duty free access of certain Indian products

Press Trust of India  |  Washington 

The US has decided to review India's eligibility to enjoy duty free access for certain products in the American market under a benefit scheme.

According to the US (USTR), the is a trade preference programme designed to promote economic development by allowing duty-free entry for thousands of products from designated beneficiary countries.

The review can impact exports of those 3,500 Indian products to the US market as removal of duty benefits would make those items uncompetitive.

The Office of the US today announced that it is reviewing the eligibility of India, Indonesia, and in the based on concerns about the countries' compliance with the programme.

The reviews are based on the Trump administration's new country eligibility assessment process as well as country eligibility petitions.

For India, the country eligibility review is based on concerns related to its compliance with the market access criterion, the USTR said in a statement.

provides an to help enforce the Trump administration's key principles of free and fair trade across the globe. The is committed to ensuring that those countries who receive benefits uphold their end of the bargain by continuing to meet the eligibility criteria outlined by Congress, Deputy U S said.

We hope that India, Indonesia, and will work with us to address the concerns that led to these new reviews, he added.

last month had voted to renew the through 2020.

It also said that the petitions filed by the US dairy and medical device industries requested a review of India's benefits, given Indian trade barriers affecting American exports in those sectors.

has implemented a wide array of trade barriers that create serious negative effects on US commerce, it has alleged.

"The acceptance of these petitions and the self-initiated review will result in one overall review of India's compliance with the market access criterion," it added.

According to the USTR, the total US imports under in 2017 was USD 21.2 billion, of which was the biggest beneficiary with USD 5.6 billion, followed by (USD4.2 billion) and (USD 2.5 billion).

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, April 13 2018. 19:20 IST